Inhibitor Therapeutics (INTI) Assets (2012 - 2026)
Inhibitor Therapeutics (INTI) recorded Assets of $637,190 in Q2 2026, down 83.7% from $3.91 million a year earlier and down 55.5% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics reported Assets of $2.51 million, down 55.9% from FY2024.
- Annual Assets has declined for three straight years, though with a five-year compound annual growth rate of 80.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $5.69 million in FY2024 (-36.4%), $8.95 million in FY2023 (-25.3%), $11.98 million in FY2022 and $58,784 in FY2021 (-55.4%).
- The Q2 2026 figure is the lowest quarterly Assets since Q3 2022.
- On a year-over-year basis, Assets has declined for 11 consecutive quarters, with an average decline of 52.0% over the last eight quarters.
- Over the past five years, the year-over-year decline in Assets ranged from 10.8% (Q3 2021) to 83.7% (Q2 2026).
- Per Business Quant, the preceding three quarters came in at $1.43 million (Q1 2026), $2.51 million (Q4 2025) and $3.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 637,190.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 637,190.00 |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 3.14 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 5.69 Mn |
| Sep 30, 2024 | 6.45 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | 7.79 Mn |
| Dec 31, 2023 | 8.95 Mn |
| Sep 30, 2023 | 9.61 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 10.84 Mn |
| Dec 31, 2022 | 11.98 Mn |
| Sep 30, 2022 | 63,117.00 |
| Jun 30, 2022 | 38,517.00 |
| Mar 31, 2022 | 61,143.00 |
| Dec 31, 2021 | 58,784.00 |
| Sep 30, 2021 | 92,518.00 |
API Access
Inhibitor Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();